Mistake 6: Injecting into the wrong tissue layer GLP-1 medications are designed for subcutaneous injection, meaning into the fat layer between the skin and the muscle
Richard, University of Gothenburg, Sweden Updates Copyright 2025 Aristizbal-Colorado, Corredor-Rengifo, Sierra-Castillo, Lpez-Corredor, Vernaza-Trujillo, Weir-Restrepo, Izquierdo-Condoy, Ortiz-Prado, Rico-Fontalvo, Gmez-Mesa, Abreu-Lomba and Rivera-Martnez
In 1980 Jean-Pierre Raufman, a young gastroenterologist (figure 33), and John Pisano, a biochemist at the National Institute of Health with a fascination for venoms, began investigating the effect of peptides found in the saliva of the lizard on human physiology
These are powerful medications with real side effects and specific medical indications
Combined with behavioural interventions, semaglutide 2.4 mg achieves an average 15% weight loss at 1 year, while tirzepatide 15 mg reaches 22% at its top dose of 15 mg
Meta-analysis and observational studies have shown that Indian patients respond to GLP-1 RAs similarly to populations globally 2 , 3
